Neural mechanisms of risk and resilience in early childhood irritability (Diversity Supplement - E. Peterson)
Neural mechanisms of risk and resilience in early childhood irritability (Diversity Supplement - E. Peterson)
批准号:
10800598
负责人:
LEA R DOUGHERTY
金额:
$8.95万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-01 至 2025-06-30
关键词:
6 year oldAgeAngerBrainChildChild RearingChildhoodClinicalCognitionDevelopmentDiseaseDisease remissionEarly DiagnosisEarly InterventionEvaluationFrustrationFutureGoalsImageLife StressLinkLongevityMeasuresMental disordersNeural PathwaysNeurophysiology - biologic functionNursery SchoolsParentsPersonsPhasePreventivePsychopathologyResearch Domain CriteriaRewardsRiskRoleSchool-Age PopulationSymptomsTemperamentTimeWorkbrain behaviorcontextual factorsearly childhoodexperiencefirst gradefollow-upfunctional outcomesinnovationmachine learning methodmiddle childhoodneuralneural circuitneural networkneuromechanismnovelprecision medicinepreventresiliencereward processingsexstressor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Irritability, defined as lowered threshold for anger when experiencing the RDoC construct frustrative non-reward,
i.e., failing to receive expected rewards, is one of the most common reasons for pediatric psychiatric evaluation.
Our work shows that early detection is critical: If irritability in preschool-age (3-6 years, before 1st grade) continues
into school-age (after 1st grade), as it does for approximately 50% of preschool-age irritable children, such
persistent irritability puts children on the path to mental disorder across the lifespan. Thus, identifying the neural
mechanisms by which children persist vs. remit in irritability is paramount to intervene in the earliest phase of
the clinical cascade. Irritability is linked with abnormalities in reward processing, which may lead to greater
frustration when rewards are not received. Such reward processing vulnerabilities may be ameliorated by better
inhibitory control, which normatively increases with maturation. However, the interplay between reward
processing and inhibition in irritability trajectories is unknown. Investigating longitudinal changes in neural
circuitry during this developmental period is important because the reward- and inhibition-related neural networks
undergo substantial change and may be most malleable to early intervention. Our overall goal is to identify
reward- and inhibition-related neural pathways that characterize persistence vs. remission of early childhood
irritability. To this end, the proposed project will longitudinally characterize the neural and symptom trajectories
of preschool-age children into school-age. We will collect measures of reward- and inhibitory control-related
brain function at baseline and 24-month follow-up from 215 5-6-year-old children prior to 1st grade, alongside
assessments of child irritability and inhibition at each 6-month follow-up. A comprehensive assessment of child
(cognition, temperament, psychopathology), parent (psychopathology) and contextual factors (e.g., parenting,
stressors) will also be assessed at baseline and 24-month assessments. Our central hypothesis is that young
children with reward- and inhibition-related neural deficits are more likely to persist in irritability compared to
those who remit. Specific aims are to identify (1) concurrent contributions of reward- and inhibition-related neural
function to irritability at each age (preschool-age, school-age); (2) developmental changes in reward- and
inhibition-related neural mechanisms of irritability trajectories from early to middle childhood; (3) early childhood
reward- and inhibition-related neural predictors of irritability trajectories and future psychopathology; and (4) the
moderating role of child sex, parent psychopathology, parenting, and life stress on these brain-behavior
associations. This proposal will advance the field by revealing the neural circuitry of irritability risk and resilience.
Innovative aspects include focusing on a key age range (5-6 years) to prevent later disorders, multiple time
point imaging, and machine learning methodology. Our project is significant because it will pave the way for
precision medicine for irritability: providing the right treatment (based on neural mechanisms) to the right people
(children who will persist in irritability), at the right time (preschool age, before irritability problems worsen).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development and Initial Trial of Brief Interventions to Help Parents of Stigmatized Youth Reduce Distress and Strengthen Attachment
-
批准号:10741051
-
项目类别:
-
资助金额:$46.37万
-
财政年份:2023
-
负责人:LEA R DOUGHERTY
-
依托单位:
Neural mechanisms of risk for irritability across the transition to adolescence
-
批准号:10549332
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2021
-
负责人:LEA R DOUGHERTY
-
依托单位:
Neural mechanisms of risk for irritability across the transition to adolescence
-
批准号:10363637
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2021
-
负责人:LEA R DOUGHERTY
-
依托单位:
Neural mechanisms of risk and resilience in early childhood irritability
-
批准号:10663081
-
项目类别:
-
资助金额:$67.95万
-
财政年份:2020
-
负责人:LEA R DOUGHERTY
-
依托单位:
Neural mechanisms of risk and resilience in early childhood irritability
-
批准号:10240710
-
项目类别:
-
资助金额:$70.43万
-
财政年份:2020
-
负责人:LEA R DOUGHERTY
-
依托单位:
Neural mechanisms of risk and resilience in early childhood irritability
-
批准号:10459590
-
项目类别:
-
资助金额:$68.82万
-
财政年份:2020
-
负责人:LEA R DOUGHERTY
-
依托单位:
Temperamental Low PE and HPA Reactivity in Preschoolers
-
批准号:7219307
-
项目类别:
-
资助金额:$2.95万
-
财政年份:2006
-
负责人:LEA R DOUGHERTY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: